Original Article

Year: 2014 | Month: September | Volume 1 | Issue 1

Improvement of Mandibular Bone Mass in Postmenopausal Osteoporotic Patients with the Treatment of Zoledronic Acid

M. I. Majumder M. A. S. I. Harun A. K. Shoma and M. Uddin
DOI:Coming Soon

Aim:

 
Aim: The aim of this study was to see the improvement of mandibular bone mass (MABM) in postmenopausal osteoporotic patients treated with bisphosphonate (zoledronic acid). Materials and Methods: A total of 150 postmenopausal osteoporotic patients were divided into two groups under the condition of treated and non-treated. All patients had been evaluated by dual-energy X-ray absorptiometry, radiovesiography. Result: Pixel intensity value of mandibular alveolar bone was significantly different between osteoporosis and treated osteoporosis group (P < 0.05). Conclusion: There are significant improvements of MABM in postmenopausal osteoporotic patient treated with zoledronic acid.

Print This Article Email This Article to Your Friend

© International Journal of Dental and Medical Specialty | Printed by Renu Publishers. 3784578 - Visitors since June 1, 2015